Showing results (2901-2910 of 6,177) with videos related to
Sort By:
Pageof 618
Nature Medicine|August 1, 2022
Large-scale genome-wide association study of coronary artery disease in genetically diverse populationsCatherine Tcheandjieu, Xiang Zhu, Austin T Hilliard, et al.Nature Medicine|August 4, 2022
Anti-inflammatory clearance of amyloid-β by a chimeric Gas6 fusion proteinHyuncheol Jung, Se Young Lee, Seongjoon Lim, et al.Nature Medicine|May 27, 2020
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trialBruno Bockorny, Valerya Semenisty, Teresa Macarulla, et al.Nature Medicine|May 7, 2021
BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiologyCamille Bigenwald, Jessica Le Berichel, C Matthias Wilk, et al.Nature Medicine|June 26, 2020
Determinants of COVID-19 disease severity in patients with cancerElizabeth V Robilotti, N Esther Babady, Peter A Mead, et al.Nature Medicine|May 6, 2021
Delayed production of neutralizing antibodies correlates with fatal COVID-19Carolina Lucas, Jon Klein, Maria E Sundaram, et al.Nature Medicine|January 26, 2023
Early detection of visual impairment in young children using a smartphone-based deep learning systemWenben Chen, Ruiyang Li, Qinji Yu, et al.Nature Medicine|August 15, 2022
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim resultsChristine D Palmer, Amy R Rappaport, Matthew J Davis, et al.Nature Medicine|November 10, 2022
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive declineRik Ossenkoppele, Alexa Pichet Binette, Colin Groot, et al.Nature Medicine|September 10, 2021
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trialPhilippe Bégin, Jeannie Callum, Erin Jamula, et al.Pageof 618